recall
saveSOMERSET THERAPEUTICS LLC recall (Cls III)
December 24, 2025updated 5mo ago
community read0 votes
Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70069-151-01; 10 x 20 Single dose vials per Carton, NDC 70069-151-10. — Reason: Subpotent product:out of specification assay results observed during long term stability testing. — Status: Ongoing
view source ↗Data sources
last refreshed 31m ago
Found something off?
same company · ±60 days · 6
- recallSOMERSET THERAPEUTICS LLC recall (Cls III)Dec 24, 2025
- recallSOMERSET THERAPEUTICS LLC recall (Cls III)Dec 24, 2025
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalELTROMBOPAG OLAMINE: ELTROMBOPAG OLAMINE — FDA approvalJan 14, 2026
🐶 often sniffed alongside
top 8- tagRecall23 co-mentions · 13 sources
- drugHALOPERIDOL11 co-mentions · 7 sources
- drugHALOPERIDOL DECANOATE11 co-mentions · 7 sources
- drugdexamethasone SR6 co-mentions · 1 sources
- drugCISATRACURIUM BESYLATE6 co-mentions · 3 sources
- drugdexamethasone sodium phosphate SR4 co-mentions · 1 sources
- drugdexamethasone sodium phosphate4 co-mentions · 1 sources
- drugatropine2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that